Abstract
Here, we demonstrate the application of the proteomic approach to the study of a transgenic mouse model of heart failure and provide an example of a disease-associated protein alteration that can be observed using this approach. Specifically, we applied the proteomic approach to the analysis of a mouse model of dilated cardiomyopathy in which the small GTPase, Rac1, was constitutively expressed specifically in the myocardium. We utilized the methods of two-dimensional gel electrophoresis (2-DE) for protein separation, silver-staining for protein visualization and mass spectrometry (MALDI-TOF and MS/MS) for protein spot identification. Computer-generated composite images were created which represent a normalized average of four 2-DE gel images derived from analysis of either Rac1 transgenic (n = 4) or non-transgenic (n = 4) mice. Analysis of composite images derived from NTG and Rac1 experimental groups revealed numerous statistically significant differences in mean protein spot intensities. Here, we report a statistically significant increase, of approximately 1.6-fold, in the mean protein spot intensity for creatine kinase M-chain in the composite image of Rac1 transgenic mice compared to control. This protein alteration may be consistent with an end-stage heart failure phenotype in which maximal myocardial reserve is employed to sustain survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ceconi C, Cargnoni A, Curello S, Ferrari R: Recognized molecular mechanisms of heart failure: approaches to treatment. Rev Port Cardiol 17(suppl II): 79-91, 1998
Colucci WS: Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997
Pleibner KP, Soding P, Sander S, Oswald H, Neun M, Regitz-Zagrosek V, Fleck E: Dilated cardiomyopathy-associated proteins and their presentation in a WWW-accessible two-dimensional gel protein database. Electrophoresis 18: 802-808, 1997
Corbett JM, Why HJ, Wheeler CH, Richardson PJ, Archard LC, Yacoub MH, Dunn MJ: Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 19: 2031-2042, 1998
Heinke MY, Wheeler CH, Chang D, Einstein R, Drake-Holland A, Dunn MJ, dos Remedios GC: Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 19: 2021-2030, 1998
Heinke MY, Wheeler CH, Yan JX, Amin V, Chang D, Einstein R, Dunn MJ, dos Remedios CG: Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 20: 2086-2093, 1999
Weekes J, Wheeler CH, Yan JX, Weil J, Eschenhagen T, Scholtysik G, Dunn MJ: Bovine dilated cardiomyopathy: Proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 20: 898-906, 1999
Clerk A, Sugden PH: Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 86: 1019-1023, 2000
Sussman MA, Welch S, Walker A, Klevitsky R, Hewet T, Price RL, Schaefer E, Yager K: Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest 105: 875-886, 2000
Neverova I, Van Eyk J: Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics 2: 22-31, 2002
Barany K, Barany M, Giometti CS: Polyacrylamide gel electrophoretic methods in the separation of structural muscle proteins. J Chromatogr A 698: 301-332, 1995
Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68: 850-858, 1996
Knecht M, Regitz-Zagrosek V, Pleissner KP, Jungblut P, Steffen C, Hilderbrandt A, Fleck E: Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J 15(suppl D): 37-44, 1994
Schaub MC, Hefti MA, Harder BA and Eppenberger HM: Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75: 901-920, 1997
Ingwall JS: The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Heart J 5(suppl F): 129-139, 1984
Neubauer S, Frank M, Hu K, Remkes H, Laser A, Horn M, Ertl G, and Lohse MJ: Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J Mol Cell Cardiol 30: 803-810, 1998
Aspenstrom P: Effectors for the Rho GTPases. Curr Opin Cell Biol 11: 95-102, 1999
Bereiter-Hahn j, Luck M, Miebach T, Stelzer HK, Voth M: Spreading of trypsinized cell: Cytoskeletal dynamics and energy requirements. J Cell Sci 96: 171-188, 1990
Luse DS, Kochel T, Kuempel ED, Coppola JA, Cai H: Transcription initiation by RNA polymerase II in vitro. At least two nucleotides must be added to form a stable ternary complex. J Biol Chem 262: 289-297, 1987
Shiraishi J, Tatsumi T, Keira N, Akashi K, Mano A, Yamanaka S, Matoba S, Asaayama J, Yaoi T, Fushiki S, Fliss H, Nakagawa M: Important role of energy-dependent mitochondrial pathways in cultured rat cardiac apoptosis. Am J Physiol Heart Circ Physiol 281: H1637-H1647, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buscemi, N., Doherty-Kirby, A., Sussman, M.A. et al. Proteomic analysis of Rac1 transgenic mice displaying dilated cardiomyopathy reveals an increase in creatine kinase M-chain protein abundance. Mol Cell Biochem 251, 145–151 (2003). https://doi.org/10.1023/A:1025402520506
Issue Date:
DOI: https://doi.org/10.1023/A:1025402520506